Accretion Nutraveda Ltd vs Accretion Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Accretion Nutraveda Ltd is ₹ 253.5 as of 05 May 15:24 . The P/E Ratio of Accretion Nutraveda Ltd is 0 as of March 2024 .The P/E Ratio of Accretion Pharmaceuticals Ltd is 0 as of March 2024 . The Market Cap of Accretion Nutraveda Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Accretion Pharmaceuticals Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Accretion Nutraveda Ltd is 0 % as of March 2024 .The Dividend Payout of Accretion Pharmaceuticals Ltd is 0 % as of March 2024.

About Accretion Nutraveda Ltd

Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f.
May 2, 2025. The Company, established at Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO), offering specialized services to a diverse range of clients across the various industries.
It specialize in ayurvedic and nutraceutical products including Tablets, Capsules, Oral Liquids, Oral Powders, External Preparation and Oils.
Apart from these, it offer a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. The products include Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.

About Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014.
Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

FAQs for the comparison of Accretion Nutraveda Ltd and Accretion Pharmaceuticals Ltd

Which company has a larger market capitalization, Accretion Nutraveda Ltd or Accretion Pharmaceuticals Ltd?

Market cap of Accretion Nutraveda Ltd is 188 Cr while Market cap of Accretion Pharmaceuticals Ltd is 126 Cr

What are the key factors driving the stock performance of Accretion Nutraveda Ltd and Accretion Pharmaceuticals Ltd?

The stock performance of Accretion Nutraveda Ltd and Accretion Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Nutraveda Ltd and Accretion Pharmaceuticals Ltd?

As of May 5, 2026, the Accretion Nutraveda Ltd stock price is INR ₹260.0. On the other hand, Accretion Pharmaceuticals Ltd stock price is INR ₹114.05.

How do dividend payouts of Accretion Nutraveda Ltd and Accretion Pharmaceuticals Ltd compare?

To compare the dividend payouts of Accretion Nutraveda Ltd and Accretion Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.